Binding of Cbl to a Phospholipase Cγ1-docking Site on Platelet-derived Growth Factor Receptor β Provides a Dual Mechanism of Negative Regulation*

Ubiquitin conjugation to receptor tyrosine kinases is a critical biochemical step in attenuating their signaling through lysosomal degradation. Our previous studies have established Cbl as an E3 ubiquitin ligase for ubiquitinylation and degradation of platelet-derived growth factor receptor (PDGFR) α and PDGFRβ. However, the role of endogenous Cbl in PDGFR regulation and the molecular mechanisms of this regulation remain unclear. Here, we demonstrate that endogenous Cbl is essential for ligand-induced ubiquitinylation and degradation of PDGFRβ; this involves the Cbl TKB domain binding to PDGFRβ phosphotyrosine 1021, a known phospholipase C (PLC) γ1 SH2 domain-binding site. Lack of Cbl or ablation of the Cbl-binding site on PDGFRβ impedes receptor sorting to the lysosome. Cbl-deficient cells also show more PDGF-induced PLCγ1 association with PDGFRβ and enhanced PLC-mediated cell migration. Thus, Cbl-dependent negative regulation of PDGFRβ involves a dual mechanism that concurrently promotes ubiquitin-dependent lysosomal sorting of the receptor and competitively reduces the recruitment of a positive mediator of receptor signaling.

[1]  Philippe Soriano,et al.  Evolutionary Divergence of Platelet-Derived Growth Factor Alpha Receptor Signaling Mechanisms , 2003, Molecular and Cellular Biology.

[2]  C. Betsholtz,et al.  Role of platelet-derived growth factor in mesangium development and vasculopathies: lessons from platelet-derived growth factor and platelet-derived growth factor receptor mutations in mice , 2004, Current opinion in nephrology and hypertension.

[3]  Todd R. Golub,et al.  Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation , 1994, Cell.

[4]  T. Pawson,et al.  Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-γ1 complexed with a high affinity binding peptide , 1994, Cell.

[5]  Y. Yarden,et al.  Src promotes destruction of c-Cbl: Implications for oncogenic synergy between Src and growth factor receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Kurosaki,et al.  Cutting edge: association of phospholipase C-gamma 2 Src homology 2 domains with BLNK is critical for B cell antigen receptor signaling. , 1999, Journal of immunology.

[7]  D. Bowtell,et al.  The Cbl protooncoprotein stimulates CSF‐1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation , 1999, The EMBO journal.

[8]  B. Druker,et al.  The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Heldin,et al.  cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules , 1988, Molecular and cellular biology.

[10]  C. Betsholtz,et al.  A specific requirement for PDGF-C in palate formation and PDGFR-α signaling , 2004, Nature Genetics.

[11]  C. Heldin,et al.  Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3' kinase. , 1994, Oncogene.

[12]  L. Claesson-Welsh.  Mechanism of action of platelet-derived growth factor. , 1996, The international journal of biochemistry & cell biology.

[13]  C. Heldin,et al.  Effect of receptor kinase inactivation on the rate of internalization and degradation of PDGF and the PDGF beta-receptor , 1991, The Journal of cell biology.

[14]  S. Lipkowitz,et al.  Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl). , 2005, Blood.

[15]  D. Bar-Sagi,et al.  hSpry2 Is Targeted to the Ubiquitin-Dependent Proteasome Pathway by c-Cbl , 2003, Current Biology.

[16]  M. Naramura,et al.  Altered thymic positive selection and intracellular signals in Cbl-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Mu-ming Poo,et al.  Signal transduction underlying growth cone guidance by diffusible factors , 1999, Current Opinion in Neurobiology.

[18]  A. Kazlauskas,et al.  Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively , 1993, Molecular and cellular biology.

[19]  H. Stenmark,et al.  Endosomal and non-endosomal functions of ESCRT proteins. , 2006, Trends in cell biology.

[20]  C. Heldin,et al.  Platelet‐derived growth factor in human glioma , 1995, Glia.

[21]  S. Ryu,et al.  Cbl competitively inhibits epidermal growth factor-induced activation of phospholipase C-gamma1. , 2003, Molecules and cells.

[22]  Rick A. Rogers,et al.  Cbl-mediated Ubiquitinylation Is Required for Lysosomal Sorting of Epidermal Growth Factor Receptor but Is Dispensable for Endocytosis* , 2003, Journal of Biological Chemistry.

[23]  H. Bito,et al.  Phosphatidylinositol 4,5-Bisphosphate Induces Actin Stress-Fiber Formation and Inhibits Membrane Ruffling in Cv1 Cells , 2001, The Journal of cell biology.

[24]  C. Heldin,et al.  Mechanisms of platelet‐derived growth factor–induced chemotaxis , 2001, International journal of cancer.

[25]  Kazuhiro Yoshida,et al.  Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach. , 2006, International journal of oncology.

[26]  L. Cantley,et al.  The Cbl Phosphotyrosine-binding Domain Selects a D(N/D)XpY Motif and Binds to the Tyr292Negative Regulatory Phosphorylation Site of ZAP-70* , 1997, The Journal of Biological Chemistry.

[27]  S. Rhee,et al.  Regulation of phosphoinositide-specific phospholipase C. , 2001, Annual review of biochemistry.

[28]  T. Roberts,et al.  Oncogenes, growth factors, and signal transduction. , 1989, The New England journal of medicine.

[29]  C. Betsholtz,et al.  Developmental roles of platelet‐derived growth factors , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[30]  Michael Loran Dustin,et al.  Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins , 2004, Nature Immunology.

[31]  A. Kazlauskas,et al.  Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal , 1993, Cell.

[32]  C. Heldin,et al.  Pool of ligand‐bound platelet‐derived growth factor β‐receptors remain activated and tyrosine phosphorylated after internalization , 1993, Journal of cellular physiology.

[33]  I. Dikic,et al.  Cbl–CIN85–endophilin complex mediates ligand-induced downregulation of EGF receptors , 2002, Nature.

[34]  C. Bucana,et al.  Expression of activated platelet‐derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential , 2006, International journal of cancer.

[35]  H. Band,et al.  Cbl-mediated Negative Regulation of Platelet-derived Growth Factor Receptor-dependent Cell Proliferation , 1999, The Journal of Biological Chemistry.

[36]  T. Takenawa,et al.  Phosphorylation of phospholipase Cgamma1 on tyrosine residue 783 by platelet-derived growth factor regulates reorganization of the cytoskeleton. , 1998, Experimental cell research.

[37]  C. Heldin,et al.  Retention of PDGFR-beta function in mice in the absence of phosphatidylinositol 3'-kinase and phospholipase Cgamma signaling pathways. , 2000, Genes & development.

[38]  I. Mellman.  Endocytosis and molecular sorting. , 1996, Annual review of cell and developmental biology.

[39]  Philippe Soriano,et al.  Roles of PDGF in animal development , 2003, Development.

[40]  Y. Yarden,et al.  c-Cbl Is a Suppressor of the Neu Oncogene* , 2000, The Journal of Biological Chemistry.

[41]  Andrew R. Cherenson,et al.  The structure of an antigenic determinant in a protein , 1984, Cell.

[42]  C. S. Raymond,et al.  PDGF signaling specificity is mediated through multiple immediate early genes , 2007, Nature Genetics.

[43]  S. Rosenkranz,et al.  Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes. , 1999, Growth factors.

[44]  V. Litvak,et al.  Sprouty Fine-Tunes EGF Signaling through Interlinked Positive and Negative Feedback Loops , 2003, Current Biology.

[45]  H. Kim,et al.  Platelet-derived growth factor signaling and human cancer. , 2003, Journal of biochemistry and molecular biology.

[46]  U. Hellman,et al.  Identification of two C‐terminal autophosphorylation sites in the PDGF beta‐receptor: involvement in the interaction with phospholipase C‐gamma. , 1992, The EMBO journal.

[47]  K. Plate,et al.  Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[48]  I. Dikic,et al.  Cbl escapes Cdc42-mediated inhibition by downregulation of the adaptor molecule βPix , 2006, Oncogene.

[49]  B. Zetter,et al.  Regulation of chemotaxis by the platelet-derived growth factor receptor-β , 1994, Nature.

[50]  M. Ladanyi,et al.  Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells , 2003, Oncogene.

[51]  S. Lipkowitz,et al.  A Conserved DpYR Motif in the Juxtamembrane Domain of the Met Receptor Family Forms an Atypical c-Cbl/Cbl-b Tyrosine Kinase Binding Domain Binding Site Required for Suppression of Oncogenic Activation* , 2004, Journal of Biological Chemistry.

[52]  E. Stanley,et al.  CSF‐1 stimulated multiubiquitination of the CSF‐1 receptor and of Cbl follows their tyrosine phosphorylation and association with other signaling proteins , 1999, Journal of cellular biochemistry.

[53]  Angel W. Lee,et al.  A Juxtamembrane Tyrosine in the Colony Stimulating Factor-1 Receptor Regulates Ligand-induced Src Association, Receptor Kinase Function, and Down-regulation* , 2004, Journal of Biological Chemistry.

[54]  J. Penninger,et al.  Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. , 2004, Immunity.

[55]  P. Courtoy,et al.  Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C. , 2000, Molecular biology of the cell.

[56]  Andrew C. Chan,et al.  BLNK Required for Coupling Syk to PLCγ2 and Rac1-JNK in B Cells , 1999 .

[57]  Y. Yarden,et al.  The RING Finger of c-Cbl Mediates Desensitization of the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[58]  S. Hubbard,et al.  Structural Characterization of a Novel Cbl Phosphotyrosine Recognition Motif in the APS Family of Adapter Proteins* , 2005, Journal of Biological Chemistry.

[59]  C. Heldin,et al.  Ligand-induced ubiquitination of the platelet-derived growth factor beta-receptor plays a negative regulatory role in its mitogenic signaling. , 1993, The Journal of biological chemistry.

[60]  D. Bowtell,et al.  Tissue Hyperplasia and Enhanced T-Cell Signalling via ZAP-70 in c-Cbl-Deficient Mice , 1998, Molecular and Cellular Biology.

[61]  H. Larjava,et al.  EXOGENOUS PHOSPHOLIPASE C STIMULATES EPITHELIAL CELL MIGRATION AND INTEGRIN EXPRESSION IN VITRO , 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[62]  L. Kay,et al.  NMR dynamics-derived insights into the binding properties of a peptide interacting with an SH2 domain. , 2005, Biochemistry.

[63]  D. Nam,et al.  Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[64]  H. Band,et al.  Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity , 1997, Molecular and cellular biology.

[65]  R. Niedenthal,et al.  c-Cbl binds to tyrosine-phosphorylated neurotrophin receptor p75 and induces its ubiquitination. , 2004, Cellular signalling.

[66]  H. Band,et al.  Cbl-mediated Negative Regulation of the Syk Tyrosine Kinase , 1998, The Journal of Biological Chemistry.

[67]  M. Babst.  A Protein's Final ESCRT , 2005, Traffic.

[68]  Scott D Emr,et al.  The ESCRT complexes: structure and mechanism of a membrane-trafficking network. , 2006, Annual review of biophysics and biomolecular structure.

[69]  T. Kurosaki,et al.  Cbl-b Positively Regulates Btk-mediated Activation of Phospholipase C-γ2 in B Cells , 2002, The Journal of experimental medicine.